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This study aimed to evaluate if macular autofluorescence (MAF) is a valuable, non-invasive follow-up parameter for cystoid 
macular edema. A total of 71 eyes (71 cases) with cystoid macular edema (CME) were included in the study. Macular pigment 
(MP) was evaluated using HRA2 (infrared) IF and FA models. The density of MP was graded into three categories: without, 
partial, and normal amount of MP. A comparison was made between the baseline (before the first administration) level and at 
the fourth month, following three consecutive intravitreal lucentis injections every month. The morphology and distribution of 
MAF, and the density and distribution of MP were regarded as the main outcome measures. At the baseline visit, all eyes with 
CME had petaloid/irregular-shaped MAF in the macular area (100%). No MAF was detected in the control eyes (0). There was 
significant difference in MAF between the CME and normal groups (P=0.000). At the fourth monthly visit, normal levels of 
MP density without MAF was detected in 68 eyes (95.8%) with the best corrected spectacular visual acuity increasing to at 
least 1 line accordingly. We conclude that macular MAF can be used as a follow-up parameter for patients with CME. MP and 
MAF can indirectly reflect the fovea cone function. 
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Cystoid macular edema (CME), which is characterized by 
cystic retinal thickening or lipid deposition, still remains 
one of the major causes of blindness. It is prone to relapse 
following successful treatment. CME is a complex patho-
logical process that has been demonstrated to be caused by 
multiple factors, including breakdown of the inner and outer 
blood-retinal barriers, oxidative stress, and elevated levels 
of vascular endothelial growth factor. 
It still remains a challenge in clinical practice, not only 
because CME is difficult to treat, but also it is highly prone 
to relapse following successful treatment. New drugs, which 
are administered via intravitreal injection, have emerged in 
recent years to become the first line treatment for diabetic 
macular edema (DME) that affects the central macula with 
loss of vision. Laser photocoagulation is still the gold 
standard of treatment for cases of CME that do not involve 
the central macular.  
Intravitreal injection of anti-VEGF drugs have become 
the first line of treatment for CME that affects the central 
macula with loss of vision, however, due to its short effec-
tive duration, the drug needs to be injected monthly. It is 
necessary to have a non-invasive, routine method to detect 
the response of the treatments. Fundus fluorescein angi-
ography (FFA) and optical coherence tomography (OCT) 
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have been accepted as the gold standards for the diagnosis 
of macular edema [1]. Leakage of the micro-vessels in the 
macular eye, as well as the morphology of macular edema 
can be visualized with FFA. For DME, leaking microaneu-
rysms contribute to foveal leakage in the early views, 
whereas the extent of the edema in the mid and late views 
can be demonstrated with FFA. However FFA is an inva-
sive examination tool; the examination duration is longer, 
and it is difficult to use in clinical practice as a follow-up 
method, especially for elderly patients with poor general 
condition. Macular thickening, the shape of the sub-retinal 
spaces and the presence of vitreal traction can be observed 
by OCT, providing precise evaluation of retinal pathology 
in CME. However, the information of intuitive structure and 
overall morphology of ME is less evident [1–2].  
In recent years, the autofluorescence (AF) technique has 
emerged and has been widely accepted as a non-invasive 
examination technique at the cellular level to observe retinal 
pigment epithelium (RPE) distribution [3]. The anato-
mo-pathologic correlations of AF findings have been estab-
lished in animal studies [3]. Owing to the convenient in-
spection process, it has been widely applied in follow-up 
patients with several diseases such as age related macular 
degeneration [4], retinal pigmentosa [3], and Best disease 
[5]. In this study, we evaluate the correlation of AF and 
macular pigment density in patients with pre- and post- lu-
centis treated CME, and further aim to provide a 
non-invasive routine follow-up tool by studying the correla-
tions of the macular pigment density and the morphology of 
macular edema.  
1  Study patients and inclusion criteria 
A total of 71 eyes (71 cases) with DME (16 eyes), CME 
secondary to central vein occlusion (CRVO, 30 eyes) and 
branch vein occlusion (BRVO, 23 eyes) Coat’s disease (2 
eyes), and non-infectious uveitis that received intravitreal 
injections of lucentis in Beijing Tongren Eye Center from 
2012.8–2013.10 were included in this study. Enrolled in this 
study were 38 males and 33 females, aged 27–82 years old 
(54.82±14.70) with a minimum follow-up of one year. The 
contralateral eyes or eyes from the age- and sex-matched 
normal subjects were used as the control. 
All patients provided signed informed consent before in-
travitreal anti-VEGF treatment. 
1.1 Clinical examination and Diagnostic criteria  
Biomicroscopic features of CME included the presence of 
serous retinal detachment and disappearance of fovea light 
reflection. The diagnosis of CME was based on OCT find-
ings, which are characterized by several dark cavities in the 
neuronal retina. FFA inclusion criteria includes petal-like 
hyperfluorescence in the late stages.  
DME, CME secondary to BRVO, CRVO, non-infectious 
uveitis and Coat’s disease were diagnosed using the pa-
tient’s medical history, indirect ophthalmoscopy, mydriatic 
fundus photography and fluorescein fundus angiography 
(FFA).   
The best corrected spectacular visual acuity (BSVA) was 
measured using standard Chinese logMAR acuity charts. 
Changed BSVA was defined as a loss or gain of more than 
10 logMAR letters; otherwise, it was defined as unchanged. 
FFA was performed using the Heidelberg HRA2 fundus 
angiography system.  
Eyes were followed up by BSVA, AF, MP and OCT 
every month. 
1.2  Intravitreal injection of Lucentis 
Eyes in which macular edema was determined to be >250 
µm by OCT and in which the duration of CME was at 
least >2 months received intravitreal injections of lucentis. 
The treatment strategy was three plus P.R.N during the first 
year of follow-up. Patients were asked to follow up every 
month. The intravitreal injection protocol was described 
previously [5]. 
1.3  Detection of auto-fluorescence and macular   
pigment 
MAF and MP were recorded with a confocal laser scanning 
laser ophthalmoscope (Retinal Angiograph 2; Heidelberg 
Engineering, Heidelberg, Germany). The high-resolution 
image field was set to: view 55° and 1536×1536 pixels. The 
pupil was dilated to a diameter of >6 mm for MAF and MP 
detection. Fluorescent angiography (FA mode without fluo-
rescein injection, excitation wavelength 488 nm) mode and 
infrared (IR mode, wavelength 830 nm, intensity of 100%) 
light was used to detect MP. FA (without injection of fluo-
rescein) was applied for detection of macular MAF. 
1.4  Grading of macular pigment and MAF 
According to Zhang et al. [6], macular pigment is graded 
into three categories: those without foveal MP, those with 
partial pigment and those with normal amounts of MP. 
These categories were compared with auto-fluorescence and 
OCT. Auto-fluorescence was graded into two categories: 
exist and non-exist. 
1.5  Statistical analysis 
All data are presented as meansstandard error of the mean 
(SEM). Data analysis was performed with the GraphPad 
Prism (version 4.0, San Diego, CA, USA). The Fisher Exact 
Test was used to compare the continued variance for CME 
and the normal control groups. The Monte Carlo exact test 
was used to find out the correlations between the two vari-
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ance MP and MAF, Linear-by-Linear association test was 
used to test the two variance to explain if there is a linear 
trend, P<0.05 was considered statistically different. 
2  Results 
2.1  Auto-fluorescence in the macular 
At the baseline visit, all 71 cases of CME showed petal-like 
or irregular fluorescence images in FFA. The petal-like or 
irregular appearance and the location of the lesion were 
detected by MAF accordingly (Figure 1). However, MAF is 
not correlated with the patient's age, sex and type of the 
primary diseases (BRVO, CRVO，diabetic retinopathy or 
Coat’s disease). MAF was not detected in the normal eyes. 
At the fourth monthly visit, MAF was detected in 2 eyes 
(2.8%). There is a significant difference between the two 
groups (P=0.000). 
2.2  Macular pigment density in normal and study eyes 
At the baseline visit, MP was not detected in any of the 
study eyes; however, normal amounts of MP were detected 
in 100% of the control normal eyes. At the fourth monthly 
follow-up visit, the percentage of normal amount of MP, 
partial MP and without MP was 68 (95.8%), 2 (2.8%), 1 
(1.4%) respectively in the CME group; normal amount MP 
was detected in all the control eyes (Figure 2) there is a sig-
nificant difference in the two groups (P=0.000). MP is not 
correlated with the patient’s age, sex and type of the prima-
ry diseases (BRVO, CRVO, diabetic retinopathy or coat’s 
disease) 
A Linear-by-Linear Association test revealed that there is 
linear trend between the two variables (Table 1). MP was 
negatively correlated with MAF in this study (2=42.123, 
P=0.000). The Kappa coefficient is 1.00. 
2.3  Correlations of MAF, MP and foveal cone function 
A total of 22 eyes (30.98%) with a BSVA of 20/200 or 
worse had no MP in the fovea, but MAF could be detected 
accordingly. Furthermore, 3 eyes (4.23%) with BSVA of 
20/40 or better had normal amounts of MP but MAF could 
not be detected. At the fourth monthly visit, normal 
amounts of MP density without MAF was found in 19 eyes  
Table 1   The correlation of fundus auto-fluorescence and macular pig-
ment density in cystoid macular edemaa) 
 Baseline N (%) 4 Month visit N (%)
Grading of MP   
Normal 0 (0%) 2 (2.82%) 
Partial 0 (0%) 69 (97.18%) 
No MP 71(100%) 0 (0.00) 
MAF   
Detectable signal 71(100%) 0 (0%) 
Reduced signal 0 (0%) 69 (97.18%) 
Not detectable 0 (0%) 2 (2.82%) 
a) Kappa coefficient (to measure the agreement between two methods 




Figure 1  Color fundus photo of a right eye with diabetic macular edema (A). Macular autofluorescence of the eye (B) and late angiographic image (C) the 
performance in the fovea consistent with round shape of high fluorescence (white arrows) which is surround by dark macular pigment. Color fundus photo of 
the same eye after three intravitreal injections of Lucentis (D). The signal of the hyperflorence which is surrounded by irregular dark macular pigment is 
reduced compared with the eye post-intravitral injection of lucentis (E) (white arrow). OCT (D) shows cystoid macular changes and retinal thickening in the 
right eye (the topographic maps of retinal thickness pre-operation (424 µm) and post-operation (320 µm, (F)). 
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Figure 2  Color fundus image of a normal eye (A) macular area presents a complete macular pigment without detectable macular autoflorence (B, white 
arrow). OCT showed normal retinal layers of the structure (C). 
(26.77%), and 11 eyes (15.49%) has no MP in the fovea 
with the BSVA of 20/200 or worse (Table 2 and 3). The 
correlations of BSVA between pre- and post-intravitreal 
injections of lucentis is summarized in Figure 3. 
A significant difference in BSVA- and MP-MAF was 
found between pre- and post-operation groups (P1=0.000, 
P2=0.000).   
3  Discussion 
In this study, we evaluated the correlation between MAF 
and the MP density pre- and post- lucentis intravitreal injec-
tion. The findings indicate that MAF is a rapid, noninvasive 
technique that may provide new insights in the follow up of 
DME.   
 
 
Figure 3  The correlations of BCSA between pre and post IV injections. 
BCSA: the best corrected spectacle visual acuity, IV: Intravitreal injection. 
*: P<0.05. 
Table 2  Correlations of MAF, MP and foveal cone function (A Baseline 
visit (Month 1))a) 
 20/200 or worse 20/200~20/40 20/40 or better
Grading of MP    
Normal 0  3 (100%) 
Partial 0 2 (4.35%) 0 
No MP 22 (100%) 44 (95.65%) 0 
Total 22 (100%) 46 (100%) 3 (100%) 
P value 0.0000 0.0000 0.0000 
MAF    
Petal-like MAF 22 (100%) 44 (95.65%)  
Reduced signal  2 (4.35%)  
Not detectable 0 0 3 (100%) 
Total 22 (100%)  3 (100%) 
P value 0.0000 0.0000 0.0000 
a) MAF: macular auto-fluorecence, MP: macular 
Table 3  Correlations of MAF, MP and foveal cone function (Month 4)a) 
 20/200 or worse 20/200–20/40 20/40 or better
Grading of MP    
Normal 0  19 (100%) 
Partial 0 2 (4.35%) 0 
No MP 11 (100%) 4 (95.65%) 0 
Total 11 (100%) 41 (100%) 19 (100%) 
P value 0.0000 0.0000 0.0000 
MAF    
Petal-like MAF 11 (100%) 44 (95.65%)  
Reduced signal 0 0  
Not detectable 0 2 (4.35%) 3 (100%) 
Total 22 (100%)  3 (100%) 
P value 0.0000 0.0000 0.0000 
a) MAF: macular auto-fluorecence, MP: macular 
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Dysfunction of cones and photoreceptors is highly corre- 
lated with edema and cysts formation. In CME, fluid accu-
mulates in the extracellular space of the outer plexiform and 
inner nuclear layers, cyst formation occurs due to the radial 
distribution of Henle fibers in the outer plexiform layer [7]. 
Directional sensitivity and visual pigment density have been 
demonstrated in eyes with CME [6]. 
Current effective intervention for CME includes laser 
photocoagulation, surgery and drugs. Anti-VEGF therapy 
has been the first-line treatment for CME. Since the effec-
tive-time of anti-VEGF treatment is shorter within a month, 
a repeated treatment strategy is applied for most patients 
with CME, a routine non-invasive and effective examina-
tion to follow up post treat CME patients is necessary. 
In our previous pilot study (which is a small case serial 
study), it was demonstrated that MP density is highly corre-
lated with the presence of MAF [2]. One of the main func-
tions of MP is a "filtration" material which [8] can absorb 
shorter wavelength light such as blue light (absorption range 
of 400~540 nm, peak 460 nm) and protect the underneath 
cones. In normal eyes, blockage and presence of normal 
amounts of MP and macular MAF were hardly detected, but 
in some pathological conditions, reduction of the density of 
MP, could lead to transmission of the blue excitation, and 
MAF can thus be detected [9]. Formation of cysts within the 
retina in the cystoid macular edema, resulting in the dis-
placement of MP through the RPE layer, causes the pet-
al-like appearance of the MAF, suggesting that MAF and 
MP density is negatively correlated. There have been two 
hypotheses to explain the hypo-AF in CME: 1) temporary 
displacement of MP caused by the cysts, MAF was consid-
ered to be "pseudo" or "relative" AF [10] 2) the presence of 
some fluorophores inside the cysts. This hypothesis was 
puts forward as an explanation for the correlations in which 
MP density is not correlated with detectable MAF.  
Our previous study demonstrated that MP density was 
highly corrected with foveal cone functions. In this study, 
we also found that when MP density can be detected fol-
lowing intravitreal injection of anti-VEGF therapy, the vis-
ual acuity improved and MAF was accordingly non-   
detectable in the treated eyes. Furthermore, it was interest-
ing to discover that in eyes with BSVA below 20/200, no 
MP could be detected but MAF could, supporting the idea 
that MP and MAF are indicators for fovea cone function. A 
well designed clinical trial is warranted to further to quanti-
tatively study the relationship of fovea cone function and 
MP or MAF.  
The results of this study revealed that MAF and MP have 
diagnostic values in the study of this disease and can be 
utilized as follow-up parameters for a variety of diseases 
with CME. The monitoring and prognostic function of 
MAF, provides a more valuable clinical technical parame-
ter. In our previous study, we confirmed that MP is an indi-
cator of macular cone function [6]. The negative correlation 
of MP and MAF also demonstrates that AF indicates macu-
lar cone function, warranting a relatively large sample of 
clinical trials for validation. Combining the two techniques 
of OCT and MAF could provide ideal follow-up infor-
mation for patients with CME. 
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